Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: jayhawk969 who wrote (9904)	1/1/2004 12:44:57 PM
From: rkrw	Respond to of 52153

And it would be a repeat nomination for Barberich. Last time around, Spring 02, they had hired and trained a big sales force in anticipation of a final approval for soltara. Uh hum, I mean to sell xopenex. Turnaround CEO of the year I'd nominate Mike Astrue at TKTX. He cleaned up the former CEO's mess, downsized from something like 9 facilities to 2, cut back on pet projects, rationalizing r&d, settled long running litigation with GENZ signing a deal with GENZ to boot, cut the burn rate, held 50% market share head to head with GENZ in Europe. Also changed the atmosphere from one of deceit to one of honesty and the market responded, up about 4X since the change. All since his hiring in 2003.